K Illingworth

1.0k total citations
16 papers, 762 citations indexed

About

K Illingworth is a scholar working on Pathology and Forensic Medicine, Surgery and Molecular Biology. According to data from OpenAlex, K Illingworth has authored 16 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pathology and Forensic Medicine, 5 papers in Surgery and 3 papers in Molecular Biology. Recurrent topics in K Illingworth's work include Systemic Sclerosis and Related Diseases (6 papers), Dermatologic Treatments and Research (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). K Illingworth is often cited by papers focused on Systemic Sclerosis and Related Diseases (6 papers), Dermatologic Treatments and Research (3 papers) and Spine and Intervertebral Disc Pathology (3 papers). K Illingworth collaborates with scholars based in United Kingdom, Canada and South Africa. K Illingworth's co-authors include M I Jayson, AD Blann, R G Cooper, Andy Vail, Stephen J. Hopkins, Pippa Tyrrell, Nancy J. Rothwell, Ariane L. Herrick, Catherine McMahon and Andrew T. King and has published in prestigious journals such as Spine, Journal of neurosurgery and Annals of the Rheumatic Diseases.

In The Last Decade

K Illingworth

16 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K Illingworth United Kingdom	12	377	180	179	122	111	16	762
Francesco Logullo Italy	16	149 0.4×	258 1.4×	330 1.8×	92 0.8×	44 0.4×	33	990
Steven Dinsmore United States	7	126 0.3×	240 1.3×	84 0.5×	131 1.1×	31 0.3×	10	957
Fulvio Massaro Italy	17	143 0.4×	261 1.4×	233 1.3×	77 0.6×	135 1.2×	52	921
Payam Saadat Iran	13	143 0.4×	51 0.3×	89 0.5×	121 1.0×	29 0.3×	89	624
Robert Glanzman United States	9	529 1.4×	354 2.0×	46 0.3×	101 0.8×	73 0.7×	14	1.1k
Raeburn B Forbes United Kingdom	17	288 0.8×	475 2.6×	51 0.3×	149 1.2×	24 0.2×	26	1.0k
A. Wright United States	13	122 0.3×	28 0.2×	94 0.5×	206 1.7×	38 0.3×	31	909
Cem Yıldırım Türkiye	18	146 0.4×	49 0.3×	112 0.6×	82 0.7×	19 0.2×	74	915
Tetsuya Mori Japan	19	462 1.2×	205 1.1×	24 0.1×	115 0.9×	12 0.1×	68	1.0k
C. D. Betts United Kingdom	6	152 0.4×	144 0.8×	81 0.5×	61 0.5×	9 0.1×	8	644

Countries citing papers authored by K Illingworth

Since Specialization

Citations

This map shows the geographic impact of K Illingworth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Illingworth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Illingworth more than expected).

Fields of papers citing papers by K Illingworth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Illingworth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Illingworth. The network helps show where K Illingworth may publish in the future.

Co-authorship network of co-authors of K Illingworth

This figure shows the co-authorship network connecting the top 25 collaborators of K Illingworth. A scholar is included among the top collaborators of K Illingworth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Illingworth. K Illingworth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Mackens, Shari, Michaël De Brucker, K Illingworth, Herman Tournaye, & Christophe Blockeel. (2021). P–619 Oral dydrogesterone (OD) versus micronized vaginal progesterone (MVP) for luteal phase support (LPS) in IVF/ICSI: a double blind, cross-over, pharmacokinetic study. Human Reproduction. 36(Supplement_1). 2 indexed citations

Galea, James, Kayode Ogungbenro, Sharon Hulme, et al.. (2017). Reduction of inflammation after administration of interleukin-1 receptor antagonist following aneurysmal subarachnoid hemorrhage: results of the Subcutaneous Interleukin-1Ra in SAH (SCIL-SAH) study. Journal of neurosurgery. 128(2). 515–523. 90 indexed citations

McMahon, Catherine, Stephen J. Hopkins, Andy Vail, et al.. (2012). Inflammation as a predictor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. Journal of NeuroInterventional Surgery. 5(6). 512–517. 113 indexed citations

Selvarajah, Johann, Craig J. Smith, Sharon Hulme, et al.. (2011). Does Inflammation Predispose to Recurrent Vascular Events after Recent Transient Ischaemic Attack and Minor Stroke? the North West of England Transient Ischaemic Attack and Minor Stroke (NORTHSTAR) Study. International Journal of Stroke. 6(3). 187–194. 19 indexed citations

Emsley, Hedley, Craig J. Smith, C Gavin, et al.. (2007). Clinical outcome following acute ischaemic stroke relates to both activation and autoregulatory inhibition of cytokine production. BMC Neurology. 7(1). 5–5. 70 indexed citations

Illingworth, K. (2005). The effects of dyslexia on the work of nurses and healthcare assistants. Nursing Standard. 19(38). 41–48. 29 indexed citations

Illingworth, K. (2005). The effects of dyslexia on the work of nurses and healthcare assistants. Nursing Standard. 19(38). 41–48. 12 indexed citations

Herrick, Ariane L., K Illingworth, A Blann, et al.. (1996). Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.. Annals of the Rheumatic Diseases. 55(2). 122–127. 93 indexed citations

Cooper, R G, Anthony J. Freemont, J A Hoyland, et al.. (1995). Herniated Intervertebral Disc-Associated Periradicular Fibrosis and Vascular Abnormalities Occur Without Inflammatory Cell Infiltration. Spine. 20(5). 591–598. 106 indexed citations

10.

Snowden, Neil, Beatrice Coupes, Ariane L. Herrick, et al.. (1994). Plasma TGF beta in systemic sclerosis: a cross-sectional study.. Annals of the Rheumatic Diseases. 53(11). 763–767. 35 indexed citations

11.

Blann, AD, K Illingworth, & M I Jayson. (1993). Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon.. PubMed. 20(8). 1325–30. 95 indexed citations

12.

Klimiuk, P S, K Illingworth, Rodney Gush, et al.. (1992). A double blind placebo controlled trial of recombinant tissue plasminogen activator in the treatment of digital ischemia in systemic sclerosis.. PubMed. 19(5). 716–20. 10 indexed citations

13.

Cooper, R G, William Mitchell, K Illingworth, et al.. (1991). The Role of Epidural Fibrosis and Defective Fibrinolysis in the Persistence of Postlaminectomy Back Pain. Spine. 16(9). 1044–1048. 66 indexed citations

14.

Cooper, R G, William Mitchell, K Illingworth, & M I Jayson. (1991). Fibrinolytic Enhancement with Stanozolol Fails to Improve Symptoms and Signs in Patients with Post-surgical Back Pain. Scandinavian Journal of Rheumatology. 20(6). 414–418. 3 indexed citations

15.

Jayson, M I, et al.. (1991). A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis.. Annals of the Rheumatic Diseases. 50(1). 41–47. 17 indexed citations

16.

Klimiuk, P S, Earle B. Kay, K Illingworth, et al.. (1988). 158 Tissue plasminogen activator (t-PA) in the treatment of digital ischaemia in systemic sclerosis (SS): Further observations. Fibrinolysis and Proteolysis. 2. 69–69. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact